L
Laura Smits De Vries
Researcher at Utrecht University
Publications - 3
Citations - 736
Laura Smits De Vries is an academic researcher from Utrecht University. The author has contributed to research in topics: Cancer & Internal medicine. The author has an hindex of 2, co-authored 2 publications receiving 660 citations.
Papers
More filters
Journal ArticleDOI
Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study
Chantal B.E.M. Reusken,Bart L. Haagmans,Marcel A. Müller,Carlos Gutierrez,Gert Jan Godeke,Benjamin Meyer,Doreen Muth,V. Stalin Raj,Laura Smits De Vries,Victor M. Corman,Jan Felix Drexler,Saskia L. Smits,Yasmin El Tahir,Rita de Sousa,Janko van Beek,Norbert Nowotny,Norbert Nowotny,Kees van Maanen,Ezequiel Hidalgo-Hermoso,Berend Jan Bosch,Peter J. M. Rottier,Albert D. M. E. Osterhaus,Christian Gortázar-Schmidt,Christian Drosten,Marion Koopmans +24 more
TL;DR: Both titres and seroprevalences in sera from different locations in Oman suggest widespread infection of camel populations, and possible animal reservoirs of MERS-CoV are investigated by assessing specific serum antibodies in livestock.
Journal ArticleDOI
Crimean-Congo Hemorrhagic Fever Virus Subunit Vaccines Induce High Levels of Neutralizing Antibodies But No Protection in STAT1 Knockout Mice
Jeroen Kortekaas,R.P.M. Vloet,Alexander J. McAuley,Xiaoli Shen,Berend Jan Bosch,Laura Smits De Vries,Rob J. M. Moormann,Rob J. M. Moormann,Dennis A. Bente +8 more
TL;DR: It is suggested that neutralizing antibodies against CCHFV do not correlate with protection of STAT1 knockout mice, and the development of subunit vaccines and their efficacy in signal transducer and activator of transcription 1 (STAT1) knockout mice is reported.
Proceedings ArticleDOI
1351 Preclinical mechanism of action and pharmacodynamic biomarker studies of DuoBody®-CD3xB7H4 in solid cancer models
Louise A. Koopman,Madelon Paauwe,Laura Smits De Vries,Frosso Karaiskaki,Marcel Brandhorst,Patrick Franken,Theo S. Plantinga,Stefanie A. H. de Poot,Mischa Houtkamp,Kate Sasser,Esther C W Breij +10 more
TL;DR: In this paper , the authors evaluated the prevalence of B7H4 expression in solid cancers and investigated the preclinical mechanism of action (MoA) and pharmacodynamic (PD) markers associated with DuoBody-CD3xB7H 4 biological activity in vitro and in vivo.